Article
Osteogenesis Imperfecta: Current and Prospective Therapies.
Biomolecules - 10 Oct 2021
Botor Malwina, Fus-Kujawa Agnieszka, Uroczynska Marta, Stepien Karolina L, Galicka Anna, Gawron Katarzyna, Sieron Aleksander L
Abstract excerpt
Osteogenesis Imperfecta (OI) is a group of connective tissue disorders with a broad range of phenotypes characterized primarily by bone fragility. The prevalence of OI ranges from about 1:15,000 to 1:20,000 births. Five types of the disease are commonly distinguished, ranging from a mild (type I) to a lethal one (type II). Types III and IV are severe forms allowing survival after the neonatal period, while type V...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
